AIM-HI Accelerator Fund

📢 Applications Now Open: AIM-HI Women’s Venture Competition & BRACE Award Venture Competition! The AIM-HI Accelerator Fund is thrilled to announce that applications are open for two unique opportunities to drive innovation in oncology: 🌟 AIM-HI Women’s Venture Competition This annual competition, launched in partnership with the National Foundation for Cancer Research, is exclusively for women-led oncology companies. Eligible companies must have at least one senior leadership woman with an equity stake. Since 2020, it has empowered female scientist-entrepreneurs through seed funding, expert coaching, and access to a global network. 🌍 BRACE Award Venture Competition In collaboration with the Asian Fund for Cancer Research, the BRACE Award is open to any oncology company working to make a difference in cancers prevalent in underserved populations. This program bridges academic innovation with real-world solutions through strategic investment. 🔗 Both competitions welcome early-stage oncology companies worldwide seeking pre-seed, seed, and Series A investments. ⏳ Application Deadline: Saturday, March 15, 2025, at 11:55 PM ET. 🎯 Don’t miss this opportunity to propel your oncology startup to the next level. 👉 Learn more and apply today: https://hubs.ly/Q0314GCq0 #WomenInSTEM #OncologyInnovation #CancerResearch #Entrepreneurship #FundingOpportunities

🌟✨ Happy New Year! ✨🌟 As we welcome 2025, AIM-HI is filled with gratitude for your support and passion in advancing cancer innovations. Together, we’re driving breakthroughs and bringing hope to patients worldwide. Here’s to another year of collaboration, progress, and making a difference—because the fight against cancer doesn’t stop, and neither do we. Wishing you a happy, healthy, and successful New Year! 🥂🎉 #HappyNewYear #AIMHI #AdvancingInnovation #FightingCancerTogether

As we close the chapter on 2024, we at AIM-HI Accelerator Fund are filled with immense gratitude for the strides we've made together this year. 🚀✨ This year has been one of innovation, collaboration, and hope. From accelerating groundbreaking oncology startups to fostering partnerships across the globe, your support has been the catalyst for everything we do. You’ve helped us move closer to transforming bold ideas into lifesaving breakthroughs for cancer patients worldwide. But the fight is far from over. As we look ahead to 2025, we remain as committed as ever to our mission: fast-tracking innovations to revolutionize cancer care and ultimately save lives. Let’s keep the momentum going! With your help, we can continue funding cutting-edge science and empowering the entrepreneurial spirit that drives progress. 🌟 Donate today and make a tangible impact on the future of cancer treatment. Together, we can ensure that 2025 is another year of hope, impact, and progress. https://hubs.ly/Q030PSZn0 Thank you for standing with us and for believing in a brighter future. Here's to everything we’ve accomplished together—and all we will achieve in the year ahead. 💙 #ThankYou #YearEndGiving #AcceleratingInnovation #AIMHI #DonateToCureCancer

🎄✨ Happy Holidays from all of us at AIM-HI! ✨🎄 This season, we reflect on the impact we’ve made together in accelerating breakthroughs in cancer research and patient care. Your support fuels innovation and brings us closer to a future without cancer. Here’s to a bright and hopeful new year filled with discovery, collaboration, and progress. Thank you for being part of this journey with us! #HappyHolidays #AIMHI #TogetherWeCan #CancerResearch #InnovationForCures

✨ Ending 2024 Strong. Accelerating Impact in 2025. ✨ As we close out this year, the fight against cancer continues to push boundaries — and so do we. The AIM-HI Accelerator Fund stands at the forefront of driving bold innovations that transform breakthroughs in cancer research into life-saving treatments for patients worldwide. Your support fuels hope and impact. Together, we can accelerate the next generation of oncology startups and fast-track solutions that save lives. 📅 Before the year ends, join us and drive cures forward! 🔗 https://hubs.ly/Q02_X-cs0 #AccelerateImpact #EndCancer #YearEndGiving #CancerResearch #SupportInnovation

🔬 Explore a Breakthrough in MRI Technology 🌟 Join a free NIH webinar on December 18th to learn about an innovative Signal Amplification By Reversible Exchange (SABRE) catalyst that enhances Magnetic Resonance Imaging (MRI) for real-time metabolic imaging. Hear directly from co-inventor Rolf Swenson, Ph.D., about this groundbreaking method that could revolutionize diagnostics for cancer, cardiovascular disease, stroke, and more. 📅 When: Wednesday, December 18, 2024 ⏰ Time: 11:00 am - 12:00 pm ET Why attend? Discover novel MRI hyperpolarization methods. Engage with the inventor and explore partnership opportunities. Understand applications for cancer diagnostics, cardiovascular imaging, and more. This cutting-edge technology reduces costs, eliminates the need for metals like gadolinium, and offers faster results—all while retaining catalytic activity for multiple cycles. Who should attend? Business development professionals Biotech/pharma researchers Investors and entrepreneurs looking to partner with NIH 🔗 Register now to secure your spot! https://hubs.ly/Q02_4GXR0 #MedicalInnovation #MRI #CancerResearch #TechTransfer #NIHWebinar

🌟 This #GivingTuesday, let’s accelerate the fight against cancer! 🌟 At AIM-HI Accelerator Fund, we’re transforming groundbreaking research into life-saving treatments by supporting oncology startups and fueling innovative solutions. Together, we can turn hope into tangible impact for cancer patients worldwide. 💡💪 Your gift today could be the catalyst for the next big breakthrough. Join us in the fight—because every discovery starts with a spark. ✨ ➡️ Donate now: https://hubs.ly/Q02-7Rpd0 #AccelerateCures #GivingTuesday #CancerResearch #InnovationInAction

Happy Thanksgiving from all of us at AIM-HI Accelerator Fund! 🦃🍂 Today, we’re filled with gratitude for the innovators, entrepreneurs, and supporters who are driving the next breakthroughs in cancer treatments. Together, we’re turning bold ideas into life-saving realities. 💡💛 #Thanksgiving #Gratitude #CancerInnovation #AIMHI

🚀 Bridging the Gap Between Innovation and Impact 🎗️ Too many life-saving scientific breakthroughs in oncology never make it out of the lab due to a lack of early-stage funding—a gap known as the "Valley of Death." This is where the AIM-HI Accelerator Fund (AIM-HI) steps in. Created by the National Foundation for Cancer Research (NFCR), AIM-HI is a 501(c)(3) non-profit organization to empower #oncology startups with the resources and support they need to drive cutting-edge cancer research from the lab bench to the clinic—and ultimately to the patients whose lives depend on these breakthroughs. 🌟 Watch how we #DriveCuresForward: https://lnkd.in/eswzTe2q 💡 Learn about our key programs such as the AIM-HI Women's Venture Competition, BRACE Award Venture Competition, and the AIM-HI Beacon Award for Women Leaders in Oncology. Together, we are revolutionizing the future of cancer treatment and generating sustainable impact for patients worldwide. 💙 Support our mission: https://bit.ly/47VzZJE Let’s close the gap and save lives. #AIMHIaccelerator #CancerResearch #Innovation #Startups #ImpactInvesting Sujuan Ba Franklin Salisbury, Jr. Charlie Weatherspoon Matt Tremblay, Ph.D. Rose Wang OncoDaily Asian Fund for Cancer Research

Have you heard? The 2025 NFCR Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship, co-hosted by AIM-HI, will be held on Friday, October 24, 2025, in-person at the National Press Club in Washington, DC. Join this day to celebrate #CancerResearch and #entrepreneurship and interact with key opinion leaders in the #oncology field, including world-class scientists, #biotech executives, entrepreneurs, #investors, cancer patients, and advocates. Missed the 2024 Event? Watch the videos on our YouTube channel: https://lnkd.in/eQRyr7Pg Support AIM-HI and our mission: https://bit.ly/47VzZJE National Foundation for Cancer Research (NFCR) Asian Fund for Cancer Research OncoDaily